Biomarin Pharmaceutical (BMRN) Shares Issued (2016 - 2025)
Historic Shares Issued for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $7000.0.
- Biomarin Pharmaceutical's Shares Issued fell 9985.41% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year decrease of 7229.46%. This contributed to the annual value of $49.3 million for FY2024, which is 2894.76% down from last year.
- Biomarin Pharmaceutical's Shares Issued amounted to $7000.0 in Q3 2025, which was down 9985.41% from $7.7 million recorded in Q2 2025.
- Biomarin Pharmaceutical's Shares Issued's 5-year high stood at $29.4 million during Q2 2024, with a 5-year trough of $7000.0 in Q3 2025.
- Moreover, its 5-year median value for Shares Issued was $11.3 million (2022), whereas its average is $13.6 million.
- Per our database at Business Quant, Biomarin Pharmaceutical's Shares Issued skyrocketed by 17445.1% in 2022 and then crashed by 9985.41% in 2025.
- Biomarin Pharmaceutical's Shares Issued (Quarter) stood at $16.3 million in 2021, then surged by 56.08% to $25.5 million in 2022, then tumbled by 41.87% to $14.8 million in 2023, then plummeted by 46.9% to $7.9 million in 2024, then tumbled by 99.91% to $7000.0 in 2025.
- Its Shares Issued was $7000.0 in Q3 2025, compared to $7.7 million in Q2 2025 and $7.9 million in Q4 2024.